$0.5335
-0.20-26.92%
In chiusura: -
$0.5740
0.047.59%
After hour: Oct 3, 7:54 PM EDT
Comments
Loading...
Stime degli utili, EPS e fatturato
Leap Therapeutics segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Data degli utili
nov 12
Stima EPS
$-0.240
Stima dei ricavi trimestrali
–
Ricavi annuali
(a partire da giu 30)
(a partire da giu 30)
–
Analizza lo storico degli utili di Leap Therapeutics utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
LPTX | Leap Therapeutics | -$0.44 | -$0.24 | — | — | $0.00 | — | — | — | 11/12/2025 | |
LPTX | Leap Therapeutics | -$0.52 | -$0.29 | -$0.40 | -37.93% | $0.00 | — | $0.00 | — | 08/14/2025 | |
LPTX | Leap Therapeutics | -$0.51 | -$0.38 | -$0.37 | 2.63% | $0.00 | — | $0.00 | — | 05/13/2025 | |
LPTX | Leap Therapeutics | -$0.46 | -$0.38 | -$0.37 | 2.63% | $0.00 | — | $0.00 | — | 03/26/2025 | |
LPTX | Leap Therapeutics | -$0.51 | -$0.48 | -$0.44 | 8.33% | $0.00 | — | $0.00 | — | 11/13/2024 | |
LPTX | Leap Therapeutics | -$0.91 | -$0.43 | -$0.52 | -20.93% | $0.00 | — | $0.00 | — | 08/12/2024 | |
LPTX | Leap Therapeutics | -$3.24 | -$0.58 | -$0.51 | 12.07% | $0.00 | — | $0.00 | — | 05/13/2024 | |
LPTX | Leap Therapeutics | -$1.10 | -$0.55 | -$0.46 | 16.36% | $0.00 | — | $0.00 | — | 03/18/2024 | |
LPTX | Leap Therapeutics | -$1.30 | -$0.58 | -$0.51 | 12.07% | $0.00 | — | $0.00 | — | 11/13/2023 | |
LPTX | Leap Therapeutics | -$1.50 | -$0.90 | -$0.91 | -1.11% | $0.00 | — | $0.00 | — | 08/14/2023 | |
LPTX | Leap Therapeutics | -$0.90 | -$1.00 | -$3.20 | -220.00% | $0.00 | — | $0.00 | — | 05/15/2023 | |
LPTX | Leap Therapeutics | -$1.00 | -$1.10 | -$1.10 | 0.00% | $375.00K | $1.20M | $0.00 | -100.00% | 03/24/2023 | |
LPTX | Leap Therapeutics | -$1.40 | -$1.20 | -$1.30 | -8.33% | $375.00K | — | $0.00 | — | 11/14/2022 | |
LPTX | Leap Therapeutics | -$1.20 | -$0.10 | -$1.50 | -1400.00% | $375.00K | $80.00K | $0.00 | -100.00% | 08/12/2022 | |
LPTX | Leap Therapeutics | -$1.20 | — | -$0.90 | — | $375.00K | — | $0.00 | — | 05/13/2022 | |
LPTX | Leap Therapeutics | -$0.90 | -$1.10 | -$1.00 | 9.09% | $375.00K | $310.00K | $375.00K | 20.97% | 03/11/2022 | |
LPTX | Leap Therapeutics | -$0.90 | -$1.10 | -$1.40 | -27.27% | $375.00K | $1.51M | $375.00K | -75.17% | 11/12/2021 | |
LPTX | Leap Therapeutics | -$1.20 | -$1.20 | -$1.20 | 0.00% | $375.00K | $280.00K | $375.00K | 33.93% | 08/13/2021 | |
LPTX | Leap Therapeutics | -$5.50 | -$1.20 | -$1.20 | 0.00% | $375.00K | $190.00K | $375.00K | — | 05/14/2021 | |
LPTX | Leap Therapeutics | -$3.20 | — | -$0.90 | — | $0.00 | — | $375.00K | — | 03/12/2021 | |
LPTX | Leap Therapeutics | -$3.30 | -$1.30 | -$0.90 | 30.77% | $0.00 | $1.00M | $375.00K | -62.50% | 11/12/2020 |
Leap Therapeutics (LPTX) Guadagno per azione
Importo a sorpresa sugli utili trimestrali
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-08-14 | $-0.40 | $-0.29 | -37.9 % |
| Q1 | 2025-05-13 | $-0.37 | $-0.38 | 2.63 % |
| Q4 | 2025-03-26 | $-0.37 | $-0.38 | 2.63 % |
| Q3 | 2024-11-13 | $-0.44 | $-0.48 | 8.33 % |
Leap Therapeutics (LPTX) Entrate
Importo sorpresa sulle entrate trimestrali
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q4 | 2023-03-24 | $0 | $1.20M | -100.0 % |
| Q2 | 2022-08-12 | $0 | $80.00K | -100.0 % |
| Q4 | 2022-03-11 | $375.00K | $310.00K | 21.0 % |
| Q3 | 2021-11-12 | $375.00K | $1.51M | -75.2 % |
FAQ
Quando Leap Therapeutics (NASDAQ:LPTX) riporterà gli utili?
Si prevede che Leap Therapeutics (LPTX) fornisca risultati il novembre 12, 2025. Gli ultimi risultati sono stati pubblicati il agosto 14, 2025 per il Q2.
Quali sono stati gli ultimi utili per azione (EPS) di Leap Therapeutics (NASDAQ:LPTX)?
L'EPS effettivo era $-0.40, che mancato la stima di $-0.29.
Quali sono state le entrate di Leap Therapeutics (NASDAQ:LPTX)?
Le entrate effettive sono state $0K, che centrato la stima di $0K.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.